Alector (NASDAQ:ALEC) said AbbVie (NYSE:ABBV) has sent written notice that it is terminating the TREM2 program, the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback